论文部分内容阅读
目的分析对比奥卡西平、卡马西平治疗原发性三叉神经痛的临床效果。方法选择2014年7月至2016年7月来我院治疗原发性三叉神经痛的患者78例作为本研究对象,遵循随机原则,分为对照组和观察组,对照组给予卡马西平治疗,观察组给予奥卡西平治疗,对比两组患者治疗前、治疗1个月、2个月后疼痛度评分和临床疗效。结果观察组治疗后疼痛度评分明显低于对照组,且临床治疗有效率达97.43%,数据之间具有统计学意义(P<0.05)。结论治疗原发性三叉神经痛时应用奥卡西平治疗,与卡马西平相比,其治疗效果更加突出,能够有效缓解患者疼痛,值得在临床大力推广。
Objective To compare the clinical efficacy of oxcarbazepine and carbamazepine in the treatment of primary trigeminal neuralgia. Methods From July 2014 to July 2016, 78 patients with primary trigeminal neuralgia in our hospital were selected as the study subjects. The patients were divided into control group and observation group according to the principle of randomness. The control group was treated with carbamazepine, The observation group was given oxcarbazepine treatment. The pain scores and clinical efficacy of two groups before treatment, one month after treatment and two months after treatment were compared. Results The score of pain in the observation group was significantly lower than that of the control group, and the effective rate of clinical treatment was 97.43%. There was statistical significance between the data (P <0.05). Conclusion The treatment of primary trigeminal neuralgia with oxcarbazepine treatment, compared with carbamazepine, the treatment effect is more prominent, can effectively relieve pain in patients, it is worth in the clinical promotion.